BMS 6064 750 (Glucophage XR 750 mg)
Generic Name: metformin
Pill imprint BMS 6064 750 has been identified as Glucophage XR 750 mg.
Glucophage XR is used in the treatment of diabetes, type 2; insulin resistance syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Glucophage XR 750 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- metformin
- Imprint:
- BMS 6064 750
- Strength:
- 750 mg
- Color:
- Red
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6064
- Inactive Ingredients:
- carboxymethylcellulose sodium
hypromelloses
magnesium stearate
More about Glucophage XR (metformin)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
